Disc Medicine: Truist Securities raises target price to $115 from $83
IRON•Truist Securities raised its target price for Disc Medicine to $115 from $83.
Related News
Virgin Media O2 owners push CMA to reconsider £2 billion broadband deal
TEF•
Chinese official says economy resilient but recovery momentum remains weak
FXI•
Pine Tree acquires controlling interest in 10-property shopping center portfolio valued at $644 million
SITC•
AstraZeneca partners with Oracle to optimize clinical trials using AI
AZN•
Glass House Brands Inc: Canaccord Genuity cuts target price to $8 from $15
GLAS•